
Boston Scientific Corp. Stock Outperforms Competitors Despite Losses On The Day

I'm PortAI, I can summarize articles.
Boston Scientific Corp.'s stock fell 2.23% to $97.01, marking its fourth consecutive day of losses, yet it outperformed some competitors. Abbott Laboratories fell 2.96%, Medtronic PLC fell 0.46%, while Stryker Corp. rose 1.31%. The trading volume was significantly higher than the 50-day average. Despite losses, the stock closed 11.41% below its 52-week high.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

